Angiodynamics (ANGO) Restructuring Costs (2012 - 2026)

Angiodynamics has reported Restructuring Costs for 15 years, with the latest figure at $6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Restructuring Costs rose 98.48% year-over-year to $6.5 million; the trailing twelve-month figure through Feb 2026 stood at $15.1 million (down 31.12% YoY), and the FY2025 full-year result was $15.6 million, down 70.63% from the prior year.
• Restructuring Costs for Q1 2026 stood at $6.5 million, up from $3.6 million in the prior quarter.
• The five-year high for Restructuring Costs was $35.4 million in Q1 2024, with the low at $2.0 million in Q2 2022.
• Historically, Restructuring Costs has averaged $6.0 million across 5 years, with a median of $3.6 million in 2023.
• Annual changes were most pronounced in 2024 — Restructuring Costs surged 949.78% — and 2025, when it sank 90.71%.
• Angiodynamics' Restructuring Costs stood at $3.1 million in 2022, then surged by 102.29% to $6.2 million in 2023, then decreased by 5.17% to $5.9 million in 2024, then slumped by 38.05% to $3.6 million in 2025, then soared by 79.42% to $6.5 million in 2026.
• The last three Restructuring Costs figures came in at $6.5 million (Q1 2026), $3.6 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.